scFv-Based “Grababody” as a General Strategy to Improve Recruitment of Immune Effector Cells to Antibody-Targeted Tumors
Zheng Cai(Southern Medical University), Hongtao Zhang(Chinese Academy of Sciences), Marla Yee(University of Pennsylvania), Yasuhiro Nagai(University of Pennsylvania), Ting Fu(Deutsche Telekom (Austria)), Zhiqiang Zhu(University of Science and Technology of China), Lian Lam(University of Pittsburgh)
Cited by 15
Related Papers
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435
Magnetically Propelled Fish‐Like Nanoswimmers
|Small|2016|271